Denosumab e cambio di paradigma nella terapia dell’osteoporosi
Crossref DOI link: https://doi.org/10.1007/s40619-021-00869-6
Published Online: 2021-05-14
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Toni, Roberto
Borghi, Davide
Quarantini, Enrico
Quarantini, Marco
Text and Data Mining valid from 2021-05-14
Version of Record valid from 2021-05-14
Article History
Accepted: 1 March 2021
First Online: 14 May 2021